11th World Congress on Human Reproduction
An international conference on the latest advances in the treatment of infertility, contraception, menopause and sexual dysfunction will be held June 2nd to June 4th in Montreal at the Queen Elizabeth Hotel. The Congress is organized by the Departments of Obstetrics and Gynecology at McGill University and the University of Montreal. The Congress President is Dr. Seang LinTan, who is Chairman of Obstetrics and Gynecology at McGill University and Chief of Obstetrics and Gynecology at the McGill University Health Centre (MUHC).
"This World Congress is a major event in the field and it is the first time this meeting is being held in Canada. We have assembled a stellar cast of leading physicians and scientists who will present the latest research in the field of reproductive health." says Dr. Tan.
The program for this congress includes lectures by world-renowned physicians and scientists from around the world, including Australia, Canada, France, Israel, the United Kingdom, and the United States. Topics of interest include:
- Reproductive cloning
- Human embryonic stem cell research
- Producing a designer baby
- The decline of fertility fact or fiction?
- Contraception in women over 40 years of age
- In vitro maturation of oocytes for treatment of infertility
For interviews, journalists are asked to contact MUHC Communications in advance of the conference. Please note that cameras and microphones will not be permitted in the seminar rooms. Please see the following agenda for more information.
The language of the conference will be English.
For more information please contact:
Christine Zeindler, MSc
Communications Coordinator (Research)
McGill University Health Centre Communications Services
(514) 934-1934 ext. 36419
pager: (514) 406-1577
11th World Congress on Human Reproduction Agenda
Sunday, June 2
8:30 am 10:15 am Plenary Session
Reproductive and Therapeutic Cloning
1. Reproductive cloning of animals where are we today? Paul De Sousa (UK)
2. Cloning of human beings how feasible is it today? Jacques Cohen (USA)
3. Stem cell research and human reproduction Anne McLaren (UK)
10:15 am 11:00 am Coffee Break
11:00am 12:30 pm Concurrent Sessions
LHRH antagonists and recombinant gonadotropins.
1. The use of recombinant gonadotropins in assisted reproduction - Ernest Loumaye (USA)
2. Indications for use of LHRH antagonists in infertility treatment today Ricardo Felberbaum (Germany)
3. Single dose versus multiple dose therapy Ricardo Felberbaum (Germany)
4. Effects on implantation Sergio Oehninger (USA).
Hormone replacement therapy
1. Monitoring of patients on long term HRT Malcolm Whitehead (UK)
2. Role of soy products and other natural products for HRT - Jennifer Blake (Canada)
3. Choice between micronized progesterone and MPA Elaine Jolly (Canada)
4. Indications and timing of starting HRT in pre-menopausal women Morrie Gelfand (Canada)
Hysteroscopy and endometrial ablation
1. Hysteroscopy 2002 Jacques Hamou (France)
2. Photodynamic endometrial ablation Robert Reid (Canada)
3. Office hysteroscopy and endometrial ablation Barry Sanders (Canada)
4. Microhysteroscopy Peter O'Donovan (UK)
Abnormal uterine bleeding
1. Modern work-up for abnormal uterine bleeding Kees Wamsteker (Netherlands)
2. Diagnosis of adenomyosis by ultrasound and MRI Caroline Reinhold (Canada)
3. Pathological basis of abnormal uterine bleeding Alex Ferenczy (Canada)
4. Importance of fluid monitoring Franklin Loffer (USA)
12:30 pm 2:00 pm Lunch Break
2:00 pm 3:30 pm Concurrent Sessions
Hormone replacement therapy
1. Risks and benefits of HRT Robert Reid (Canada)
2. Risk of breast cancer with long term HRT Richard Margolese (Canada)
3. Place of life long HRT with availability of SERMS Leo Plouffe (Canada)
4. Hormonal strategy in the management of menopausal women - Marian Damewood (USA)
Update in ART
1. Feasibility of single embryo transfer in IVF Lars Hamberger (Sweden)
2. Embryo assessment to optimize pregnancy rates - Jacques Cohen (USA)
3. Cryopreservation of human oocytes David Winniger (USA)
4. Effects of league tables and strict policies on the number of embryos transferred on the practice of IVF Hossam Abdallah (Egypt)
Induction of ovulation
1. Neuroendocrinology of reproduction Robert Rebar (USA)
2. How do I choose the ideal gonadotropins for my patients? Roy Homburg (Israel)
3. Fertility drugs and breast and ovarian cancer what is the evidence? Bruno Lunenfeld (Israel)
4. Risks of ovarian stimulation and pregnancy after history of breast cancer Richard Margolese (Canada)
Laparoscopy & hysteroscopy recent developments
1. Place of laparoscopic tubal anastomosis Tae-Ki Yoon (Korea)
2. Transvaginal hydrolaparoscopy Stephen Gordts (Belgium)
3. Effects of CO2 gas on peritoneum Douglas Ott (USA)
4. Hysteroscopic vs non-hysteroscopic endometrial ablation Milton Goldrath (USA).
3:30 pm 4:00 pm Coffee Break
4:00 pm 5:30 pm Concurrent Sessions
Aging male and female
1. The andropause fact or fiction Bruno Lunenfeld (Israel)
2. Sexual dysfunction in aging men Serge Carrier (Canada)
3. Risks of growth hormone and testosterone for the aging male Howard Jacobs (UK)
4. Menopause and heart disease Wulf Utian (USA)
PCOS and infertility
1. Significance of ultrasound diagnosis of polycystic ovaries without clinical or endocrinological features Howard Jacobs (UK)
2. Rational use of metformin in PCOS associated with infertility Gabor Kovacs (Australia)
3. Surgical treatment of PCOS Adam Balen (UK)
4. Non-fertility risks of PCOS David Morris (Canada)
Endometriosis & ART
1. Optimum surgical treatment for endometriomas Liselotte Mettler (Germany)
2. Common genetic changes between endometriosis and ovarian cancer Hiroshi Hoshiai (Japan)
3. Ovarian suppression Andrea Genazzani (Italy)
4. Optimising embryo transfer an evidence-based approach Hassan Sallam (Egypt)
Uterine diseases
1. Uterine anomalies and infertility John Rock (USA)
2. Diagnosis of non-gynecological causes of pelvic pain - Albert Cohen (Canada)
3. Myoma, infertility and IVF Shlomo Mashiach (Israel.)
4 Optimal treatment of uterine synechiae Robert Neuwirth (USA).
Monday, June 3
7:00 am 8:30 am Plenary Session - Sponsored by NovoNordisk
Advances in in-vitro maturation of oocytes
1. The role of FF-MAS in in-vitro maturation of oocytes Christian Grondhal (Denmark)
2. The impact of different culture environments on the in-vitro maturation potential and genetics of human oocytes Helen Picton (UK)
3. Is IVM feasible for non-selected, non-PCO patients? Peter Plateau (Belgium)
8:30 am 10:15 am Plenary Session
The future of reproductive technologies
1. In-vitro maturation of human oocytes for the treatment of infertility Seang Lin Tan (Canada)
2. The human genome project: Relevance to human disease - Tom Hudson (Canada)
3. The designer baby Robert G. Edwards (UK)
10:15 am 11:00 am Coffee Break
11:00am 12:30 pm Concurrent Sessions
Management of infertility: "From laboratory to clinical outcomes"
A Serono Educational Event (SEE)
1. Assessing embryo quality: "A significant difference between two r-FSH preparations". Catherine Racowsky (USA)
2. German Phase III open multi-center study to evaluate the convenience and safety of recombinant FSH injections supplied as 1200 IU multi-dose (Gonal-F Multi Doseâ) in ART cycles Miguel J. Hinrichsen (Germany)
3. Optimizing outcomes in the treatment of infertility Ernest Loumaye (Switzerland)
Advances in Male factor infertility treatment
1. Testicular and epididymal sperm for ICSI Zev Rosenwaks (USA)
2. Medical treatments of erectile dysfunction Yosh Taguchi (Canada)
3. Are old sperms still good? Bernard Robaire (Canada)
4. Spermatozoon as a vehicle for HIV-I and other viruses Richard Lalonde (Canada)
Endometriosis
1. New concepts in management Liselotte Mettler (Germany)
2. HRT after BSO David Redwine (USA)
3. Should endometriomas be removed before IVF? Rene Frydman (France)
4. Is burning or excision preferable for endometriotic surgery David Redwine (USA)
Laparoscopic surgery
1. Place of laparoscopic supra-cervical hysterectomy Michelle Nisolle (Belgium)
2. Role of laparoscopic vs laparotomy for hysterectomy Christopher Sutton (UK)
3. Removal of ovaries at hysterectomy in pre-menopausal women Malcolm Whitehead (UK)
4. Laparoscopic radical hysterectomy Farr Nezhat (USA)
12:30 pm 2:00 pm Lunch Break
2:00 pm 3:30 pm Concurrent Sessions
Assisted Reproductive Technology
1. Micro anatomy of human IVF and early embryo genesis Pietro Motta (Italy)
2. Blastocyst culture does it improve pregnancy rates? Amin Milki (USA)
3. Recombinant FSH and LH Zeev Shoham (Israel)
4. Nuclear and cytoplasmic transfer Jacques Cohen (USA)
SERMS
1. Advances in SERM therapy Wulf Utian (USA)
2. Comparison between Fosamax and Raloxifen - Malcolm Whitehead (UK)
3. Endometrial effects of SERMS Leo Plouffe (USA)
4 Prevention of osteoporosis role of SERMS David Goltzman (Canada)
Ectopic pregnancy and pelvic pain
1. Patient assisted laparoscopy Larry Demco (Canada)
2. Pain mapping by laparoscopy and miniendoscopy Larry Demco (Canada)
3. Salpingostomy vs salpingectomy Victor Gomel (Canada)
4. Non-laparoscopic evaluation of pelvic pain - Deborah Metzger (USA)
Ethics and reproduction
1. Dogmatic ethicism Albert Yupze (Canada)
2. Ethical implications of genetic screening Françoise Shenfield (UK)
3. Comparative regulatory systems governing ART Joseph Schenker (Israel)
4. Stem cell research ethical considerations - Margaret Somerville (Canada)
3:30 pm 4:00 pm Coffee Break
4:00 pm 5:30 pm Concurrent Sessions
Ultrasound and infertility
1. Place of ultrasound guided embryo transfer Sergio Oehninger (USA)
2. Requirements for certification of ultrasound Lucie Morin (Canada)
3. Management of hydrosalpinges in women undergoing IVF Mohamed Aboulghar (Egypt)
Implantation
1. The implantation window Bruce Lessey (USA)
2. Impact of oocyte quality Hugh Clarke (Canada)
3. Endometrial factors and implantation Yuji Taketani (Japan)
Menopause
1. Androgen therapy Morrie Gelfand (Canada)
2. Sex hormones and brain function Barbara Sherwin (Canada)
3. Osteoporosis Alan Tennenhouse (Canada).
Ovarian stimulation with urinary gonadotropins
1. Use of urinary gonadotropins by subcutaneous injection Albert Yuzpe (Canada)
2. Control of follicular recruitment Klaus Diedrich (Germany)
3. Role of Coasting - Jehoshua Dor (Israel)
Tuesday, June 4
8:30 am 10:15 am Plenary Session
Highlights of reproductive science
1. Decline of fertility in the human race- what is the evidence? - John Aitken (Australia)
2. Cryopreservation and transplantation of human ovarian tissue Roger Gosden (Canada)
3. Genetics of infertility David Page (USA)
10:15 am 11:00 am Coffee Break
11:00am 12:30 pm Concurrent Sessions
Management of common reproductive disorders
1. Hirsutism Vivian Lewis (USA)
2. Amenorrhea Zephne Van der Spuy (South Africa)
3. Pre-menstrual syndrome Robert Reid (Canada)
4. Hyperprolactinemia Yogesh Patel (Canada)
Recurrent pregnancy loss
1. Evidence for immunotherapy and recurrent pregnancy loss Salim Daya (Canada)
2. Thrombophilia and recurrent pregnancy loss Susan Kahn (Canada)
3. Pre-implantation genetic diagnosis as final treatment for recurrent miscarriage Asangla Ao (Canada)
4. The role of Mitochondria and Aging Ovary - Chii-Ruey Tzeng (Taiwan)
Management of the infertile couple
1. Infertility work-up 2002 Charles Coddington (USA).
2. Management of ovarian hyperstimulation syndrome Mohamed Aboulghar (Egypt)
3. Subtle factors in unexplained infertility Michael Diamond (USA)
4. Pre-conception care Alice Benjamin (Canada)
Allied Health and Patient Issues
1. Academic fertility centers strategies for cost-effective management Anna-Maria Henderson (Canada)
2. Role of support organizations Norman Barwin (Canada)
3. Counseling sperm and egg donors Janet Takefman (Canada)
4. Strategies for developing a strong support group Lone Hummelshoj (UK)
12:30 pm 2:00 pm Lunch Break
2:00 pm 3:30 pm Concurrent Sessions
Contraception Sponsored by Berlex Canada
1. Ultra low dose contraception Timothy Rowe (Canada)
2. Emergency contraception Albert Yuzpe (Canada)
3. Third generation oral contraceptives safety and indications for use Walter Spitzer (USA)
4. Treatment of acne Serge Belisle (Canada)
Genetics, aging and fertility
1. Mitochondria and oocyte aging Eric Shoubridge (Canada)
2. The genetics of infertility what about PCOS? Jennifer Wood (USA)
3. Genomic imprinting and fetal loss Jacquetta Trasler (Canada)
4. Oocyte and sperm aging and its effects on fertility - Alan Handyside (UK)
Adhesions
1. Prevention by adhesions Michael Diamond (USA)
2. Peritoneal repair Arthur Haney (USA)
3. Animal model David Wiseman (USA)
4. Growth factors Nasser Chegini (USA)
Sexually transmitted disease and reproduction
1. Ethical issues involved in the treatment of HIV positive couples Benjamin Younger (USA)
2. Why are women's groups not more active in the fight against AIDS Mark Wainberg (Canada)
3. Abnormal cytology among HIV infected women Alex Ferenczy (Canada)
4. Influence of HIV infection on PID Chris Tsoukas (Canada)
3:30 pm 4:00 pm Coffee Break
4:00 pm 5:30 pm Concurrent Sessions
Uterine artery embolization
1. Uterine artery embolization in young women is there a role? Togas Tulandi (Canada)
2. Management of uterine fibroid: an overview Charles Coddington (USA)
3. Indications and success rates for uterine artery embolization for fibroids Francis Hutchins (USA)
4. Complications of uterine artery embolization Lawrence Stein (Canada)
Contraception in women over 40 years
1. Choice of medical contraception in women over 40 years Jennifer Blake (Canada)
2. Risks: perception vs reality Timothy Rowe (Canada)
3. Management of practical problems Elaine Jolly (Canada)
4. OC until HRT benefits and risks Victoria Davis (Canada)
Meta-analyses and reproductive science
1. Meta-analysis vs large prospective randomized trial David Guzick (USA)
2. Meta-analysis strengths and weaknesses Walter Spitzer (USA)
3. Evidenced based ART treatment by meta-analysis John Collins (Canada).
4. Evidenced based infertility treatment by meta-analysis Salim Daya (Canada)
Reproductive Health and Alternative Medicine
1. Obesity and reproduction Zephne Van der Spuy (South Africa)
2. Complementary and alternative medicine Machelle Seibel (USA)
3. Infertility and energy healing Robert McInnes (USA)
4. Acupuncture and reproduction Joseph Wong (Canada)